ProMIS Neurosciences, Inc.
General ticker "PMN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.6M (TTM average)
ProMIS Neurosciences, Inc. does not follow the US Stock Market performance with the rate: -19.1%.
Estimated limits based on current volatility of 4.2%: low 6.93$, high 7.75$
Factors to consider:
- Total employees count: 7 (+16.7%) as of 2023
- Top business risk factors: Inability to raise capital, Product development risks, Market acceptance, Regulatory and compliance, Pandemic risks
- Current price 47.6% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [14.57$, 46.21$]
- 2025-12-31 to 2026-12-31 estimated range: [18.40$, 53.55$]
Financial Metrics affecting the PMN estimates:
- Positive: with PPE of -1.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -114.97 <= 0.33
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Interest expense per share per price, % of 0.32 <= 0.79
- Positive: Shareholder equity ratio, % of 87.19 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Return on assets ratio (scaled to [-100,100]) of 12.81 > 6.04
Short-term PMN quotes
Long-term PMN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $23.38MM | $18.90MM | $16.83MM |
| Operating Income | $-23.38MM | $-18.90MM | $-16.83MM |
| Non-Operating Income | $5.32MM | $1.39MM | $19.61MM |
| Interest Expense | $0.28MM | $0.20MM | $0.08MM |
| R&D Expense | $16.09MM | $7.88MM | $10.64MM |
| Income(Loss) | $-18.06MM | $-17.51MM | $2.78MM |
| Profit(Loss)* | $-18.06MM | $-21.80MM | $2.78MM |
| Stockholders Equity | $-1.35MM | $3.75MM | $16.49MM |
| Assets | $6.92MM | $13.62MM | $18.91MM |
| Operating Cash Flow | $-17.03MM | $-10.84MM | $-27.18MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $-0.00MM | $-0.00MM |
| Financing Cash Flow | $6.49MM | $17.75MM | $27.88MM |
| Earnings Per Share** | $-2.41 | $-1.77 | $0.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.